Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A reproducible and sensitive assay for melanotropic agents is described employing mouse melanoma cells in culture and measuring
tyrosinase
activity in terms of production of tritiated water from L-(ring-3,5-3H)-tyrosine. Molar concentrations of peptides inducing one-half maximal stimulation of
tyrosinase
activity were:
beta-MSH
, 1 +/- 2 x 10(-9);
alpha-MSH
and Beta h-LPH, 1 +/- 2 x 10(-8); ACTHp, 1 +/- 2 x 10(-7). Beta p 9-18-MSH and melanotropin potentiating factor, beta s 88-91-LPH exhibited no activity at concentrations as high as 10(-5)M.
...
PMID:Assay of melanotropic peptides in an in vitro mammalian system. 679 95
Melanotrophin-potentiating factor (MPF) is a fragment of human beta-lipotrophin (LPH 88-91) which potentiates the action of
alpha-MSH
on Anolis skin. In the present study, we investigated the effect of MPF on MSH-induced melanogenesis. Pooled hair follicle scrapings from Siberian hamsters (Phodopus sungorus) were incubated for 48 hours with or without
alpha-MSH
and/or MPF. Melanogenesis was monitored by measuring
tyrosinase
activity and melanin accumulation. 10-8 M MPF potentiated the effect of no effect on melanogenesis, but 10-9 to 10-7 M
alpha-MSH
caused a dose-related increase. 10-8 M MPF potentiated the effect of each dose of
alpha-MSH
. Thus MPF potentiated MSH action on mammalian melanogenesis as well as on reptilian melanosome dispersion. Although each of these processes involve different intracellular responses the receptor mechanisms involved in each may therefore be the same.
...
PMID:Melanotrophin-potentiating factor (MPF) potentiates MSH-induced melanogenesis in hair follicle melanocytes. 679 9
Pigment of tail-fin melanophores in periodic albino Xenopus laevis tadpoles is dispersed in response to darkness and to
alpha-MSH
in a manner similar to wild-type melanophores. However, periodic albino tadpoles lack the response to different background conditions and the melatonin-induced aggregation in darkness. The
tyrosinase
activity in cells of the latter type tadpoles is weak compared to the wild-type cells. Ultrastructural examination of melanophores from periodic albino mutants and cells from wild-type tadpoles shows similar organelles at corresponding sites. A morphological difference can be observed in the fine structure of the melanosomes, which in albinos resembles an earlier stage of development. It is postulated that periodic albino Xenopus laevis possess the cellular mechanism to disperse pigment in the melanophores, but that under physiological conditions the release of
alpha-MSH
appears to be absent or scarce.
...
PMID:A comparative ultrastructural and physiological study on melanophores of wild-type and periodic albino mutants of Xenopus laevis. 680 Jun 56
Human melanocytes, maintained on bovine corneal endothelium-derived extracellular matrix for at least 4 days in the absence of phorbol 12-myristate 13-acetate (PMA) and cholera toxin (CT), displayed increased
tyrosinase
activity when exposed to several pro-
opiomelanocortin
-derived (POMC) peptides. Melanocytes from 9 of 14 donors showed significantly increased
tyrosinase
activity after treatment with adrenocorticotropic hormone (ACTH; mean increase 320 +/- 107 (S.E.M.)% of control, P < 0.005), while melanocytes from 8 of 13 donors increased
tyrosinase
in the presence of diacetyl-melanocyte stimulating hormone (di-MSH; mean increase 223 +/- 31 (S.E.M.)% of control, P < 0.005). Maximal increases in
tyrosinase
were seen after treatment with 10(-10) M ACTH and with 10(-6) M di-MSH. In two cell cultures which showed
tyrosinase
stimulation, melanin synthesis was similarly increased in the presence of added POMC peptides. PMA but not CT increased
tyrosinase
activity in melanocytes cultured under these conditions. In the presence of staurosporine, an inhibitor of protein kinase C (PKC), the magnitude of the increase in
tyrosinase
due to PMA, ACTH and di-MSH was significantly reduced. These results indicate that
tyrosinase
activity in melanocytes from most human donors, under appropriate conditions, is susceptible to the stimulatory effects of POMC peptides, that ACTH is considerably more potent than di-MSH in this test system and that in human cells the PKC pathway may be important in modulating melanogenesis.
...
PMID:Stimulation of tyrosinase in human melanocytes by pro-opiomelanocortin-derived peptides. 759 39
Melanin is specifically produced in melanocytes. The pathway for melanin biosynthesis is regulated by a number of melanocyte-specific proteins, including
tyrosinase
and tyrosinase-related protein-1 (TRP-1, b locus protein). To understand the regulation of melanogenesis, we examined
tyrosinase
activities, mRNA levels of
tyrosinase
and TRP-1, and eumelanin and pheomelanin contents in mouse B16-F1 melanoma cells after they had been treated with some melanotropic reagents. Cholera toxin,
alpha-melanocyte-stimulating hormone
, and dibutyryl cyclic AMP increased
tyrosinase
activity and stimulated eumelanin biosynthesis. These reagents elevated intracellular cAMP levels. In contrast, 12-O-tetradecanoylphorbol 13-acetate reduced
tyrosinase
activity and eumelanin synthesis. In all cases, the mRNA levels of
tyrosinase
and TRP-1 changed in parallel with
tyrosinase
activity and eumelanin content. TRP-1 was induced simultaneously with
tyrosinase
, although its inducibility was lower than that of
tyrosinase
. These results suggest that the expressions of
tyrosinase
and TRP-1 genes are coordinately regulated by melanotropic reagents through cAMP-dependent protein kinase and protein kinase C in mouse B16-F1 cells, and that their coordinate expression causes eumelanin biosynthesis.
...
PMID:Eumelanin biosynthesis is regulated by coordinate expression of tyrosinase and tyrosinase-related protein-1 genes. 768 98
We have successfully established normal neonatal and adult human melanocyte cultures in a growth medium containing the physiologic mitogens basic fibroblast growth factor (bFGF; 0.6 ng/ml), endothelin-1 (endo-1; 10 nM), and alpha-melanocyte stimulating hormone (
alpha-MSH
; 10 nM). The latter two factors replaced the commonly used mitogens 12-O-tetradecanoylphorbol 13-acetate (TPA) and bovine pituitary extract (BPE), respectively. Basic FGF alone maintained the viability but did not induce the proliferation of melanocytes. The addition of endo-1 to the bFGF-containing medium resulted in reduction of
tyrosinase
activity without enhancement of proliferation. However, the addition of
alpha-MSH
to the bFGF-containing medium potentiated melanocyte proliferation and
tyrosinase
activity. The concomitant addition of endo-1,
alpha-MSH
, and bFGF significantly increased the entry of melanocytes into S phase and potentiated their proliferation. Melanocytes maintained under these conditions had the same
tyrosinase
activity as those maintained in a medium containing
alpha-MSH
and bFGF. The signal transduction pathway induced by either endo-1 or bFGF, but not
alpha-MSH
, includes the activation of the mitogen-activated (MAP) kinase pathway. The addition of both endo-1 and bFGF had more than an additive effect on the MAP kinase extracellular signal-regulated kinase 2 (ERK2). This effect was further increased by the addition of
alpha-MSH
to these two growth factors. In summary, we have devised a growth medium for human melanocytes based on the use of physiologic mitogens that substituted for routinely used artificial and undefined growth factors. The resulting cultures should be desirable for clinical uses and permissive for the expression of in vivo relevant responses to regulatory factors.
...
PMID:Long-term proliferation of human melanocytes is supported by the physiologic mitogens alpha-melanotropin, endothelin-1, and basic fibroblast growth factor. 769 46
The endogenous pentapeptides,
met-enkephalin
and leuenkephalin, similar to their parent structures,
beta-endorphin
or dynorphin, bind to opioid receptors of the nociceptive system thus provoking analgesic responses. Peroxidases and phenolases (
tyrosinase
,
catecholase
) were shown to dimerize these pentapeptides thus possibly modulating their activity and/or lifetime. Extracts from plants from the order of the Papaverales contain isoquinoline alkaloids. Since the benzoisoquinolines are known to possess sedative-hypnotic activities, the potential effects of extracts from two species from this plant group, Eschscholtzia californica (Papaveraceae) and
tyrosinase
-catalyzed dimerization and/or oxidation of
met-enkephalin
were investigated. The results of the study show that the peroxidase-catalyzed dimerization via the tyr-residues is especially inhibited by the C. cava extract. The
tyrosinase
-catalyzed reaction yields five different products A-E, according to their HPLC-retention times. Consisting of the 4:1 (v/v) combination of the extracts from E. californica and C. cava, Phytonoxon N (abbreviated as PN) stimulates the formation of minor products A, B and E, whereas the formation of the major products C and D is inhibited. Only products C and D exhibit properties similar to the peroxidase-derived dimer. Product A is likely to be identical to DOPA-enkephalin.
...
PMID:Effects of ethanolic extracts from Eschscholtzia californica and Corydalis cava on dimerization and oxidation of enkephalins. 771 Apr 33
Transfection of class I H-2Kb or H-2Kd into cells of a pigmented subclone of B16-F10 BL6 (termed BL6-8) results in the loss of melanin production. In contrast, transfected BL6-8 cells expressing H-2Dd, H-2Ld, class I H-21Ak and/or the neor genes maintained their pigmented phenotype. Melanogenesis was also inhibited in cells which expressed the endogenous H-2Kb, but not the endogenous H-2Db, gene. In order to identify the specific defects in the melanogenic pathway responsible for the absence of melanin production, factors known to be related to the regulation of pigment formation were evaluated in H-2K-expressing cells. These studies showed that: (1) transfection of BL6-8 cells with the H-2Kb or H-2Kd, but not with the H-2Dd, H-2Ld or H-21Ak, genes was associated with complete inhibition of
tyrosinase
activity; (2)
alpha-melanocyte-stimulating hormone
(MSH) and theophylline (an inhibitor of cAMP phosphodiesterase) failed to stimulate
tyrosinase
activity in H-2K-positive cells, whereas
tyrosinase
activities in untransfected, or H-2DdH-2Ld, neor or H-21Ak-transfected cells were dramatically increased by those agents; (3) treatment with MSH had no effect on cAMP levels in H-2K-positive cells but stimulated cAMP levels more than 100-fold in H-2K-negative cells; (4) in contrast to MSH, forskolin, a stimulator of adenylate cyclase, was able to stimulate cAMP levels in all cell lines tested, but in H-2Kb-positive cells the levels of forskolin-induced cAMP were significantly less than those elicited in H-2Kb-negative cells; (5) electron microscopy showed that H-2K-positive cells lacked mature melanosomes; (6) Northern blot analyses showed that H-2K-positive cells lacked mRNA for
tyrosinase
or for the MSH receptor. Taken together, expression of the endogenous or transfected H-2K gene in BL6 melanoma cells results in down-regulation of the entire melanogenic pathway, including the inhibition of
tyrosinase
and MSH receptor gene expression, cAMP responses and melanosomal biogenesis.
...
PMID:Impairment of the melanogenic pathway in B16 melanoma cells transfected with class I H-2 genes. 773 52
The influence of single amino acid replacements by alanine on the binding affinity and biological activity of
alpha-MSH
in B16 murine melanoma cells has been studied systematically.
alpha-MSH
analogues were synthesized by solid-phase peptide synthesis and their binding affinities to the melanocortin receptor expressed by B16 mouse melanoma cells were determined using a radioreceptor assay. Biological activity of the analogues was determined by measuring
tyrosinase
stimulation. Relative activity and affinity data were generally in agreement with earlier results using terminal deletion fragments of
alpha-MSH
, but the alanine scan revealed important new insights into the role of individual residues. The three terminal amino acids at either end were not necessary for binding or activity, with amino acids 4-9 forming a core sequence required for receptor binding and triggering of the biological response. It was observed that replacement of the glutamic acid residue in position 5 was possible without loss of affinity or activity, whereas replacement of Met4 resulted in a 100-fold loss of binding affinity and biological activity. Each residue within the conserved melanocortin sequence His-Phe-Arg-Trp was shown to be essential with Phe7, Arg8, and Trp9 being the most sensitive to replacement by alanine. Generally, there was a rank correlation between binding affinity and
tyrosinase
stimulation within the group of analogues studied. Tyrosinase activity was less affected by alanine substitution than binding affinity, which suggests that full receptor binding is not required for maximum biological response.
...
PMID:Synthesis and biological evaluation of alpha-MSH analogues substituted with alanine. 785 84
Although the administration of
melanocyte-stimulating hormone (MSH)
peptides results in skin darkening in man, cultured human melanocytes have been reported to be unresponsive to these peptides. This may be a consequence of the conditions under which the cells were maintained in vitro, particularly the use of phorbol esters and cholera toxin as melanocyte mitogens. By culturing the cells in the absence of these additives, we demonstrate that
alpha-MSH
and its synthetic analogue Nle4DPhe7
alpha-MSH
(NDP-MSH) induce dose-related increases in melanin content and
tyrosinase
activity and affect cell morphology in the majority of human melanocyte cultures. In addition, NDP-MSH induces increases in tyrosinase mRNA and tyrosinase-related protein-1 (TRP-1) mRNA. The dose-response curves for the MSH peptides are sigmoidal and the two peptides are equipotent in their effects on human melanocytes.
Adrenocorticotropic hormone
(
ACTH
) also affects morphology and stimulates melanogenesis and
tyrosinase
activity in human melanocytes. However, the dose-response curves for
ACTH
are biphasic, and the melanocytes respond to lower concentrations of
ACTH
than MSH peptides, similar to those normally present in human plasma. These findings may be important in understanding the role of these pro-
opiomelanocortin
peptides in human skin pigmentation.
...
PMID:Cultured human melanocytes respond to MSH peptides and ACTH. 785 66
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>